Eli Lilly | LLY - Ebitda

Preço das Ações
883.96
Mudança Diária
-33.69 -3.67%
Mensal
-3.53%
Anual
-0.07%
Q2 Previsão
865.04




Ebitda Alterar Data
AbbVie USD 3.52B 828M 2025-09
Abbott USD 3.27B 178M 2025-12
ALKERMES USD 100.31M 21.24M 2025-12
Amgen USD 5.14B 775M 2025-12
AstraZeneca USD 5.23B 272M 2025-09
Baxter International USD 426M 36M 2025-09
Biogen USD 573.2M 253.7M 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Coherus Biosciences USD -43.33M 4.7M 2025-09
Drreddys Laboratories INR 21.59B 1.49B 2025-12
Eli Lilly USD 7.88B 378.1M 2025-09
Gilead Sciences USD 3.02B 1.01B 2025-12
GlaxoSmithKline GBP 3.36B 179M 2025-09
Glaxosmithkline GBP 4.75B 1.52B 2025-09
J&J USD 7.19B 2.32B 2025-12
Medtronic USD 2.93B 482M 2025-12
Merck USD 8.39B 1.97B 2025-09
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Novartis USD 4.77B 1.11B 2025-12
Novartis USD 5.84B 235M 2025-09
Novo Nordisk DKK 37.3B 5.86B 2025-12
Perrigo USD 258.8M 37.3M 2025-09
Pfizer USD 6.08B 351M 2025-09
Phibro Animal Health USD 68.1M 6.2M 2025-12
Prestige Brands USD 90.82M 3.99M 2025-12
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 3.31B 3.65B 2026-03
Sanofi EUR 5.66B 3.77B 2025-09
United Therapeutics USD 379.5M 83.4M 2025-12
Zoetis USD 1.04B 87M 2025-09